ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HIO Healthcare Inv

14.75
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Healthcare Inv LSE:HIO London Ordinary Share GB00B94T6Y14 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 14.75 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
  -
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 14.75 GBX

Healthcare Inv (HIO) Latest News

Real-Time news about Healthcare Inv (London Stock Exchange): 0 recent articles

Healthcare Inv (HIO) Discussions and Chat

Healthcare Inv Forums and Chat

Date Time Title Posts
05/1/201415:53Healthcare from Evans26

Add a New Thread

Healthcare Inv (HIO) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Healthcare Inv (HIO) Top Chat Posts

Top Posts
Posted at 05/1/2014 15:53 by cnx
HIO now moved to COS
Posted at 30/12/2013 14:29 by doodlebug4
From an article in the Daily Mail published 31st July. Flotation was in April.

"At the time of HIO's flotation Evans was granted options over 4.05million shares (10 per cent of the equity), which will only vest in the event that an acquisition is completed within 12 months from admission, and if the share price is in excess of 20p per share.


Once vested, the exercise period of the options will be 10 years and the exercise price will be 10p per share. Evans has a big City fan club and it is easy to see why. The companies under his stewardship have a strong record of value generation for shareholders.


He was chief executive of Shield Diagnostics prior to the merger with Axis Biochemicals to form Axis Shield in 1999. He was also chairman of Immunodiagnostic Systems, which floated in December 2004 at 51p and was trading at 1046p at the time he left the company in September 2011."
Posted at 27/12/2013 15:32 by doodlebug4
Director Shareholding
RNS
RNS Number : 4668W
Healthcare Investment Opportunities
27 December 2013



27 December 2013



Healthcare Investment Opportunities Plc

(the "Company")



Director Shareholding



Healthcare Investment Opportunities plc (AIM: HIO), an investment company focusing on the healthcare sector, announces that today Malcolm Gillies, a Director of Healthcare Investment Opportunities, has purchased a total of 250,000 ordinary shares at an average price of 12.789 pence per share.



This brings Malcolm Gillies' interest in the Company's current issued share capital to 500,000 being 1.24% of the current issued share capital.
Posted at 31/7/2013 16:02 by doodlebug4
Delayed trades put through this afternoon, I suppose some of the people who bought in at the original float price in April might be happy to cash in on their profit. I'm happy to wait this one out, even if it takes 7 years for David Evans to put in a similar performance to the one when he was chairman of Immundiagnostic Systems !
Posted at 31/7/2013 14:09 by doodlebug4
Buyers paying the full offer price of 17p now.
Posted at 31/7/2013 07:45 by tpinvest
Looks like Mail readers are having a lie-in this morning.
No reaction to this news so far;

Rumours yesterday suggested David Evans is about to set pulses racing in the AIM market again. Shares of his cash shell Healthcare Investment Opportunities (HIO) touched 16.9p before closing 0.88p or 5.6 per cent up at a record 16.5p on hot gossip of an imminent transformational acquisition.
Healthcare Inv share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock